Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease
暂无分享,去创建一个
C. Forsblom | P. Groop | V. Nair | M. Kretzler | F. Kee | E. Brennan | A. McKnight | N. Sandholm | J. Cole | A. Maxwell | I. Young | K. Suszták | Hongbo Liu | C. Godson | K. Kerr | L. Smyth | P. Groop | K. Anderson | H. Liu | R. Salem | E. Dahlström | L. Smyth | J. Kilner | A. Syreeni | R. Nelson | H. Looker | C. Wooster | G. McKay | D. Andrews | J. Hirschhorn | A. Maxwell | J. Florez | A. McKnight | R. G. Nelson | H. C. Looker | G. Mckay | R. M. Salem | J. C. Florez | A. P. Maxwell | M. Kretzler | V. Nair | J. Cole | Emma Dahlstrom | R. G. Nelson | G. McKay | F. Kee | I. Young
[1] A. McKnight,et al. DNA Methylation Associated With Diabetic Kidney Disease in Blood-Derived DNA , 2020, Frontiers in Cell and Developmental Biology.
[2] J. Florez,et al. Genetics of diabetes mellitus and diabetes complications , 2020, Nature Reviews Nephrology.
[3] W. Evans,et al. ARID5B Influences Antimetabolite Drug Sensitivity and Prognosis of Acute Lymphoblastic Leukemia , 2019, Clinical Cancer Research.
[4] Angelo J. Canty,et al. Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen. , 2019, Journal of the American Society of Nephrology : JASN.
[5] Liang Liang,et al. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data , 2019, Journal of Translational Medicine.
[6] R. Krediet,et al. Long-term peritoneal dialysis treatment provokes activation of genes related to adaptive immunity. , 2019, Physiological research.
[7] Baofeng Lian,et al. The analysis of risk factors for diabetic nephropathy progression and the construction of a prognostic database for chronic kidney diseases , 2019, Journal of Translational Medicine.
[8] N. Yang,et al. Pim‐1 as a Therapeutic Target in Lupus Nephritis , 2019, Arthritis & rheumatology.
[9] K. Westover,et al. Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma , 2019, EBioMedicine.
[10] M. Luppi,et al. T-cell large granular lymphocyte leukemia in solid organ transplant recipients: case series and review of the literature , 2019, International journal of hematology.
[11] Hongzhe Li,et al. Kidney cytosine methylation changes improve renal function decline estimation in patients with diabetic kidney disease , 2019, Nature Communications.
[12] D. Tenen,et al. The enhancer RNA ARIEL activates the oncogenic transcriptional program in T-cell acute lymphoblastic leukemia. , 2019, Blood.
[13] Mitsuo Kato,et al. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory , 2019, Nature Reviews Nephrology.
[14] Hongbing Shen,et al. Identification of Novel T1D Risk Loci and Their Association With Age and Islet Function at Diagnosis in Autoantibody-Positive T1D Individuals: Based on a Two-Stage Genome-Wide Association Study , 2019, Diabetes Care.
[15] C. Gieger,et al. Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-κB–driven inflammation and cardiovascular risk , 2019, Proceedings of the National Academy of Sciences.
[16] J. Mill,et al. Guidance for DNA methylation studies: statistical insights from the Illumina EPIC array , 2019, BMC Genomics.
[17] Weihong Cao,et al. PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation , 2019, Breast cancer.
[18] Wei Zhang,et al. Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] Chao-Yan Sun,et al. Associations between Vitamin D and β-Cell Function and Colorectal Cancer-Associated Tumor Markers in Chinese Type 2 Diabetic Patients with Albuminuria. , 2019, Clinical laboratory.
[20] Safa Al-Sarraj,et al. Parallel profiling of DNA methylation and hydroxymethylation highlights neuropathology-associated epigenetic variation in Alzheimer’s disease , 2019, Clinical Epigenetics.
[21] Suman Lee,et al. The association of genetically controlled CpG methylation (cg158269415) of protein tyrosine phosphatase, receptor type N2 (PTPRN2) with childhood obesity , 2019, Scientific Reports.
[22] Y. Huang,et al. Renal cell carcinoma: predicting RUNX3 methylation level and its consequences on survival with CT features , 2019, European Radiology.
[23] T. Wong,et al. Association of Diabetic Retinopathy and Diabetic Kidney Disease With All-Cause and Cardiovascular Mortality in a Multiethnic Asian Population , 2019, JAMA network open.
[24] Saijuan Chen,et al. TAMM41 is required for heart valve differentiation via regulation of PINK-PARK2 dependent mitophagy , 2019, Cell Death & Differentiation.
[25] P. Ismail,et al. Association of CCL2, CCR5, ELMO1, and IL8 Polymorphism with Diabetic Nephropathy in Malaysian Type 2 Diabetic Patients , 2019, International journal of chronic diseases.
[26] Michael R. Elliott,et al. A non-canonical role for the engulfment gene ELMO1 in neutrophils that promotes inflammatory arthritis , 2018, Nature Immunology.
[27] Damian Szklarczyk,et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..
[28] M. Seidl,et al. Characterization of septin expression in normal and fibrotic kidneys , 2018, Cytoskeleton.
[29] R. Baybutt,et al. Cux1 regulation of the cyclin kinase inhibitor p27kip1 in polycystic kidney disease is attenuated by HDAC inhibitors. , 2019, Gene.
[30] A. McKnight,et al. Validation of differentially methylated microRNAs identified from an epigenome-wide association study; Sanger and next generation sequencing approaches , 2018, BMC Research Notes.
[31] Yu Deng,et al. Pim1 promotes cell proliferation and regulates glycolysis via interaction with MYC in ovarian cancer , 2018, OncoTargets and therapy.
[32] G. Anton,et al. Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome , 2018, Journal of immunology research.
[33] A. Advani,et al. Histone Deacetylase Inhibitors and Diabetic Kidney Disease , 2018, International journal of molecular sciences.
[34] W. McArdle,et al. Identification of loci where DNA methylation potentially mediates genetic risk of type 1 diabetes. , 2018, Journal of autoimmunity.
[35] J. Dodd,et al. Metformin and Dietary Advice for Pregnant Women Who Are Overweight or Obese to Promote Gestational Restriction of Weight—The GROW Randomized Trial , 2018, Diabetes.
[36] S. Golden,et al. Type 2 diabetes and cardiometabolic risk may be associated with increase in DNA methylation of FKBP5 , 2018, Clinical Epigenetics.
[37] M. McNerney,et al. Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS. , 2018, Blood.
[38] R. Hanson,et al. Cytosine methylation predicts renal function decline in American Indians. , 2018, Kidney international.
[39] Lili Yu,et al. PBX1 promotes the cell proliferation via JAK2/STAT3 signaling in clear cell renal carcinoma. , 2018, Biochemical and biophysical research communications.
[40] M. McCarthy,et al. A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes , 2018, Diabetes.
[41] J. Mao,et al. PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis , 2018, Cell Death & Disease.
[42] L. Canani,et al. The rs2292239 polymorphism in ERBB3 gene is associated with risk for type 1 diabetes mellitus in a Brazilian population. , 2018, Gene.
[43] Matthias Kretzler,et al. A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome. , 2017, Kidney international.
[44] L. Dimeglio,et al. Type 1 Diabetes , 2019, Epidemiology of Diabetes.
[45] T. Mahjoub,et al. Gender differences in the association of ELMO1 genetic variants with type 2 diabetes in Tunisian Arabs , 2018, Journal of Endocrinological Investigation.
[46] F. Pociot. Type 1 diabetes genome-wide association studies: not to be lost in translation , 2017, Clinical & translational immunology.
[47] Audrey Y. Chu,et al. Epigenome-wide association studies identify DNA methylation associated with kidney function , 2017, Nature Communications.
[48] R. Leslie,et al. The Role of Epigenetics in Type 1 Diabetes , 2017, Current Diabetes Reports.
[49] R. Baybutt,et al. Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model. , 2017, American journal of physiology. Renal physiology.
[50] S. Miyano,et al. Molecular studies reveal MLL-MLLT10/AF10 and ARID5B-MLL gene fusions displaced in a case of infantile acute lymphoblastic leukemia with complex karyotype , 2017, Oncology letters.
[51] A. Bansal,et al. DNA methylation and its role in the pathogenesis of diabetes , 2017, Pediatric diabetes.
[52] Sassan Noazin,et al. Early detection of gastric cancer using global, genome-wide and IRF4, ELMO1, CLIP4 and MSC DNA methylation in endoscopic biopsies , 2017, Oncotarget.
[53] F. Béna,et al. PBX1 haploinsufficiency leads to syndromic congenital anomalies of the kidney and urinary tract (CAKUT) in humans , 2017, Journal of Medical Genetics.
[54] M. McCarthy,et al. The Genetic Landscape of Renal Complications in Type 1 Diabetes. , 2017, Journal of the American Society of Nephrology : JASN.
[55] Taotao Ma,et al. Methylation of Septin9 mediated by DNMT3a enhances hepatic stellate cells activation and liver fibrogenesis , 2017, Toxicology and applied pharmacology.
[56] René A. M. Dirks,et al. Genome-wide epigenomic profiling for biomarker discovery , 2016, Clinical Epigenetics.
[57] A. Just,et al. Birth weight-for-gestational age is associated with DNA methylation at birth and in childhood , 2016, Clinical Epigenetics.
[58] Pao-Yang Chen,et al. Profiling genome-wide DNA methylation , 2016, Epigenetics & Chromatin.
[59] H. Kędzierska,et al. Expression of Genes Involved in Cellular Adhesion and Extracellular Matrix Remodeling Correlates with Poor Survival of Patients with Renal Cancer. , 2016, The Journal of urology.
[60] E. Svarstad,et al. One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease , 2016, PloS one.
[61] S. Ropero,et al. Development of Castration Resistant Prostate Cancer can be Predicted by a DNA Hypermethylation Profile. , 2016, The Journal of urology.
[62] Junnian Zheng,et al. The emerging role of RUNX3 in cancer metastasis (Review). , 2016, Oncology reports.
[63] E. Binder,et al. Gene–Stress–Epigenetic Regulation of FKBP5: Clinical and Translational Implications , 2016, Neuropsychopharmacology.
[64] E. Ziętkiewicz,et al. Impact of SNPs on methylation readouts by Illumina Infinium HumanMethylation450 BeadChip Array: implications for comparative population studies , 2015, BMC Genomics.
[65] A. Maxwell,et al. Distinct methylation patterns in genes that affect mitochondrial function are associated with kidney disease in blood‐derived DNA from individuals with Type 1 diabetes , 2015, Diabetic medicine : a journal of the British Diabetic Association.
[66] A. Schäffer,et al. Multiple microRNAs within the 14q32 cluster target the mRNAs of major type 1 diabetes autoantigens IA‐2, IA‐2β, and GAD65 , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[67] Alan B Leichtman,et al. US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[68] M. Mauer,et al. Glomerular structural-functional relationship models of diabetic nephropathy are robust in type 1 diabetic patients. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[69] S. Zhuang,et al. Treatment of chronic kidney diseases with histone deacetylase inhibitors , 2015, Front. Physiol..
[70] T. George,et al. BCL6 expression correlates with the t(1;19) translocation in B-lymphoblastic leukemia. , 2015, American journal of clinical pathology.
[71] V. Galkin,et al. Septins promote stress fiber–mediated maturation of focal adhesions and renal epithelial motility , 2014, The Journal of cell biology.
[72] A. McKnight,et al. Genetic and epigenetic factors influencing chronic kidney disease. , 2014, American journal of physiology. Renal physiology.
[73] Teruhiko Yoshida,et al. Comprehensive Exploration of Novel Chimeric Transcripts in Clear Cell Renal Cell Carcinomas Using Whole Transcriptome Analysis , 2014, Genes, chromosomes & cancer.
[74] Katalin Susztak,et al. Molecular mechanisms of diabetic kidney disease. , 2014, The Journal of clinical investigation.
[75] H. Falhammar,et al. Epigenetic analyses of the insulin-like growth factor binding protein 1 gene in type 1 diabetes and diabetic nephropathy , 2014, Clinical Epigenetics.
[76] A. McKnight,et al. DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease , 2014, Epigenetics.
[77] Elin Hall,et al. Genome-Wide DNA Methylation Analysis of Human Pancreatic Islets from Type 2 Diabetic and Non-Diabetic Donors Identifies Candidate Genes That Influence Insulin Secretion , 2014, PLoS genetics.
[78] G. Qin,et al. HDAC4: mechanism of regulation and biological functions. , 2014, Epigenomics.
[79] N. Rajakumar,et al. The effects of olanzapine on genome-wide DNA methylation in the hippocampus and cerebellum , 2014, Clinical Epigenetics.
[80] J. Hirschhorn,et al. Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes. , 2013, Journal of the American Society of Nephrology : JASN.
[81] R. Hanson,et al. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes , 2013, Diabetes.
[82] B. Kasiske,et al. Angiotensin II blockade in kidney transplant recipients. , 2013, Journal of the American Society of Nephrology : JASN.
[83] P. Pozzilli,et al. Epigenetics in autoimmune diseases with focus on type 1 diabetes , 2013, Diabetes/metabolism research and reviews.
[84] L. Li,et al. Association of ELMO1 gene polymorphisms with diabetic nephropathy in Chinese population , 2013, Journal of Endocrinological Investigation.
[85] David Staudt,et al. Uncovering the molecular and cellular mechanisms of heart development using the zebrafish. , 2012, Annual review of genetics.
[86] P. Marquet,et al. Association of sirolimus adverse effects with m-TOR, p70S6K or Raptor polymorphisms in kidney transplant recipients , 2012, Pharmacogenetics and genomics.
[87] M. Horikoshi,et al. Associations of variations in the MRF2/ARID5B gene with susceptibility to type 2 diabetes in the Japanese population , 2012, Journal of Human Genetics.
[88] Benjamin J. Keller,et al. New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes , 2012, PLoS genetics.
[89] Devin C. Koestler,et al. DNA methylation arrays as surrogate measures of cell mixture distribution , 2012, BMC Bioinformatics.
[90] Eric Meggers,et al. PIM1 kinase as a target for cancer therapy , 2012, Expert opinion on investigational drugs.
[91] Junnian Zheng,et al. RUNX3 expression is lost in glioma and its restoration causes drastic suppression of tumor invasion and migration , 2011, Journal of Cancer Research and Clinical Oncology.
[92] B. Najafian,et al. Quantitating Glomerular Endothelial Fenestration: An Unbiased Stereological Approach , 2011, American Journal of Nephrology.
[93] B. Molnár,et al. The Influence of Methylated Septin 9 Gene on RNA and Protein Level in Colorectal Cancer , 2011, Pathology & Oncology Research.
[94] R. Reeves,et al. Why target PIM1 for cancer diagnosis and treatment? , 2010, Future oncology.
[95] D. Chasman,et al. Multiple new genetic loci associated with kidney function and Chronic Kidney Disease: The CKDGen Consortium , 2010 .
[96] Stephan Beck,et al. Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus , 2010, BMC Medical Genomics.
[97] Uwe Völker,et al. New loci associated with kidney function and chronic kidney disease , 2010, Nature Genetics.
[98] J. Kaldor,et al. Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study , 2010, BMJ : British Medical Journal.
[99] H. Yoshida,et al. Association of genetic variants with chronic kidney disease in Japanese individuals with or without hypertension or diabetes mellitus. , 2010, Experimental and therapeutic medicine.
[100] E. Binder. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders , 2009, Psychoneuroendocrinology.
[101] Samy Suissa,et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. , 2009, The New England journal of medicine.
[102] J. Gécz,et al. A UPF3-mediated regulatory switch that maintains RNA surveillance , 2009, Nature Structural &Molecular Biology.
[103] G. Chaturvedi,et al. The homeodomain protein Cux1 interacts with Grg4 to repress p27 kip1 expression during kidney development. , 2009, Gene.
[104] Stephen S. Rich,et al. Genome-Wide Association Scan for Diabetic Nephropathy Susceptibility Genes in Type 1 Diabetes , 2009, Diabetes.
[105] M. Rastaldi,et al. Enhanced Expression of Janus Kinase–Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy , 2009, Diabetes.
[106] B. Balkau,et al. Evaluating the association of common APOA2 variants with type 2 diabetes , 2008, BMC Medical Genetics.
[107] B. Balkau,et al. Evaluating the association of common PBX1 variants with type 2 diabetes , 2008, BMC Medical Genetics.
[108] Christine A. Orengo,et al. Towards a comprehensive structural coverage of completed genomes: a structural genomics viewpoint , 2007, BMC Bioinformatics.
[109] J. Kaldor,et al. Cancer incidence before and after kidney transplantation. , 2006, JAMA.
[110] Felix Eichinger,et al. Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy , 2006, Diabetes.
[111] R. Klein,et al. The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study. , 2005, Diabetes.
[112] A. Pestronk,et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein , 2004, Nature Genetics.
[113] Nunzio Bottini,et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes , 2004, Nature Genetics.
[114] D. Gutsch,et al. Effect of DNA methylation and chromatin structure on ITGAL expression. , 2002, Blood.
[115] Michael E. Miller,et al. Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. , 2002, Diabetes.
[116] C. Bogardus,et al. Analysis of PBX1 as a candidate gene for type 2 diabetes mellitus in Pima Indians. , 2001, Biochimica et biophysica acta.
[117] M. Mauer,et al. Diabetic nephropathy as a model of reversibility of established renal lesions. , 1998, Current opinion in nephrology and hypertension.
[118] José Costa,et al. PicoGreen quantitation of DNA: effective evaluation of samples pre- or post-PCR , 1996, Nucleic Acids Res..
[119] Shirley A. Miller,et al. A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.